Streetbeat News

Analyst Ratings

XPO

Evercore ISI Group analyst Jonathan Chappell has upgraded XPO Logistics (NYSE:XPO) from In-Line to Outperform and raised the price target from $72 to $79.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:38 am

IMVT

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Immunovant (NASDAQ:IMVT) and raised the price target from $33 to $48.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:38 am

ETSY

Wells Fargo analyst Ken Gawrelski has maintained an Underweight rating on Etsy and lowered the price target from $70 to $60.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:34 am

DOGEUSD

FLOKIUSD

PEPEUSD

Crypto analyst Crypto Tony predicts significant price movements for meme coins in October, dubbed 'Flokitober'. He suggests that Floki token is in a crucial accumulation phase and Dogecoin (DOGE) is showing signs of a significant price surge. Another analyst, Kaleo, identifies a breakout pattern for PEPE token, indicating it's ready to run back to the highs.

Portfolio Pulse from Mehab Qureshi

September 27, 2023 | 11:33 am

TNL

Barclays analyst Brandt Montour has maintained an Equal-Weight rating on Travel+Leisure (NYSE:TNL) but lowered the price target from $43 to $38.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:27 am

SNX

Barclays analyst Tim Long has maintained an Equal-Weight rating on TD Synnex (NYSE:SNX) and raised the price target from $98 to $99.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:24 am

VAC

Barclays analyst Brandt Montour has maintained an Overweight rating on Marriott Vacations (NYSE:VAC) but lowered the price target from $131 to $118.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:22 am

COST

Raymond James analyst Bobby Griffin maintains an Outperform rating on Costco Wholesale (NASDAQ:COST) and raises the price target from $570 to $580.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:20 am

GH

Piper Sandler analyst David Westenberg has upgraded Guardant Health (NASDAQ:GH) from Neutral to Overweight and announced a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:11 am

FSLR

Citigroup analyst Vikram Bagri maintains a Neutral rating on First Solar (NASDAQ:FSLR) and lowers the price target from $214 to $200.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 11:09 am